Hydroxylation and sulfation of sex steroid hormones in inflammatory liver
Sang R. Lee, Seung-yeon Lee, Sang-yun Kim, Si-yun Ryu, Bae-kuen Park, Eui-Ju Hong
Hydroxylation and sulfation of sex steroid hormones in inflammatory liver
Sex steroids, also known as gonadal steroids, are oxidized with hydroxylation by cytochrome P450, glucuronidation by UDP-glucuronosyltransferase, sulfation by sulfotransferase, andO-methylation by catechol O-methyltransferase. Thus, it is important to determine the process by which inflammation influences metabolism of gonadal hormones. Therefore, we investigated the mechanism of metabolic enzymes against high physiologic inflammatory responsein vivo to study their biochemical properties in liver diseases. In this study, C57BL/6N mice were induced with hepatic inflammation by diethylnitrosamine (DEN) exposure. We observed upregulation of Cyp19a1, Hsd17b1, Cyp1a1, Sult1e1 in the DEN-treated livers compared to the control-treated livers using real time PCR. Moreover, the increased Cyp19a1 and Hsd17b1 levels support the possibility that estrogen biosynthesis from androgens are accumulated during inflammatory liver diseases. Furthermore, the increased levels of Cyp1a1 and Cyp1b1 in the hydroxylation of estrogen facilitated the conversion of estrogen to 2- or 4-hydroxyestrogen, respectively. In addition, the substantial increase in the Sult1e1 enzyme levels could lead to sulfate conjugation of hydroxyestrogen. The present information supports the concept that inflammatory response can sequester sulfate conjugates from the endogenous steroid hormones and may suppress binding of sex steroid hormones to their receptors in the whole body.
liver / inflammation / sex steroid hormone / steroid metabolic enzyme / cytochrome enzyme
[1] |
Kristensen VN, Borresen-Dale AL. Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism[J]. Mutat Res, 2000, 462(2-3): 323–333
Pubmed
|
[2] |
Durocher F, Sanchez R, Ricketts ML ,
Pubmed
|
[3] |
O’Neill JS, Miller WR. Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases[J]. Br J Cancer, 1987, 56(5): 601–604
Pubmed
|
[4] |
Martucci CP, Fishman J. P450 enzymes of estrogen metabolism[J]. Pharmacol Ther, 1993, 57(2-3): 237–257
Pubmed
|
[5] |
Ritter JK, Sheen YY, Owens IS . Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. 3,4-catechol estrogens and estriol as primary substrates[J]. J Biol Chem, 1990, 265(14): 7900–7906
Pubmed
|
[6] |
Hernández JS , Watson RW , Wood TC ,
Pubmed
|
[7] |
Ball P, Knuppen R. Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance[J]. Acta Endocrinol Suppl (Copenh), 1980, 232: 1–127
Pubmed
|
[8] |
Lee AJ, Kosh JW, Conney AH ,
Pubmed
|
[9] |
Lee AJ, Mills LH, Kosh JW ,
Pubmed
|
[10] |
Lord RS, Bongiovanni B, Bralley JA . Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites[J]. Altern Med Rev, 2002, 7(2): 112–129
Pubmed
|
[11] |
Song WC. Biochemistry and reproductive endocrinology of estrogen sulfotransferase[J]. Ann N Y Acad Sci, 2001, 948: 43–50
Pubmed
|
[12] |
Pasqualini JR. Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments[J]. J Steroid Biochem Mol Biol, 2005, 97(5): 401–415
Pubmed
|
[13] |
Schmidt M, Naumann H, Weidler C ,
Pubmed
|
[14] |
Shiau HJ, Aichelmann-Reidy ME, Reynolds MA . Influence of sex steroids on inflammation and bone metabolism[J]. Periodontol 2000, 2014, 64(1): 81–94
Pubmed
|
[15] |
Lv J, Xiao Q, Chen Y ,
Pubmed
|
[16] |
Sozen H, Celik OI, Cetin ES ,
Pubmed
|
[17] |
Hyun SY, Jang YJ. p53 activates G1 checkpoint following DNA damage by doxorubicin during transient mitotic arrest[J]. Oncotarget, 2015, 6(7): 4804–4815
Pubmed
|
[18] |
Weisz J, Bui QD, Roy D ,
Pubmed
|
[19] |
Lee AJ, Cai MX, Thomas PE ,
Pubmed
|
[20] |
Shimodaira M, Nakayama T, Sato I ,
Pubmed
|
[21] |
Shimada T, Hayes CL, Yamazaki H ,
Pubmed
|
[22] |
Hakkola J, Pasanen M, Pelkonen O ,
Pubmed
|
[23] |
Tang YM, Chen GF, Thompson PA ,
Pubmed
|
[24] |
Nutter LM, Ngo EO, Abul-Hajj YJ . Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells[J]. J Biol Chem, 1991, 266(25): 16380–16386
Pubmed
|
[25] |
Nutter LM, Wu YY, Ngo EO ,
Pubmed
|
[26] |
Henderson BE, Ross RK, Pike MC . Toward the primary prevention of cancer[J]. Science, 1991, 254(5035): 1131–1138
Pubmed
|
[27] |
Li JJ, Li SA, Oberley TD ,
Pubmed
|
[28] |
Emons G, Merriam GR, Pfeiffer D ,
Pubmed
|
[29] |
Adjei AA, Weinshilboum RM. Catecholestrogen sulfation: possible role in carcinogenesis[J]. Biochem Biophys Res Commun, 2002, 292(2): 402–408
Pubmed
|
[30] |
Aksoy IA, Wood TC, Weinshilboum R . Human liver estrogen sulfotransferase: identification by cDNA cloning and expression[J]. Biochem Biophys Res Commun, 1994, 200(3): 1621–1629
Pubmed
|
[31] |
Yong M, Schwartz SM, Atkinson C ,
Pubmed
|
[32] |
Hanson SR, Best MD, Wong CH . Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility[J]. Angew Chem Int Ed Engl, 2004, 43(43): 5736–5763
Pubmed
|
[33] |
Strott CA. Steroid sulfotransferases[J]. Endocr Rev, 1996, 17(6): 670–697
Pubmed
|
/
〈 | 〉 |